Daily Dose - Sep 30th, 2026
Daily Dose |
View online
September 30, 2026
Are we creating stainless-steel bioreactor dinosaurs?
Not likely, argues Kymanox Executive Advisor Roger Lias, despite recent advances in continuous manufacturing for antibodies and other recombinant biologics.
Read More
Genentech breaks ground on $750M Oregon manufacturing expansion
The 211,000-square-foot addition will add device fill-finish capabilities and combination product manufacturing to the Hillsboro site.
Read More
Serán Bioscience expands commercial spray-dry manufacturing in Oregon
The new facility will add commercial-scale particle engineering and finished-dose capabilities to Serán’s Bend manufacturing campus.
Read More